| The Matilda effect: underrecognition of women in hematology and oncology awards SR Patel, F St. Pierre, AI Velazquez, S Ananth, U Durani, ... The oncologist 26 (9), 779-786, 2021 | 44 | 2021 |
| Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System CR Frei, H Le, D McHugh, K Ryan, X Jones, S Galley, K Franklin, CJ Baus, ... Leukemia & Lymphoma 62 (7), 1664-1673, 2021 | 11 | 2021 |
| Treatment patterns and outcomes of 1205 patients on novel agents in the US Veterans Health Administration (VHA) system: results from the largest retrospective EMR and chart … CR Frei, H Le, D McHugh, C Elesinmogun, S Galley, K Franklin, J Tavera, ... Blood 134, 795, 2019 | 5 | 2019 |
| Aggressive eosinophilic granulomatosis with polyangiitis and transverse sinus thrombosis S Ananth, R Sankaralingam, M Manoj Case Reports 2016, bcr2015213099, 2016 | 5 | 2016 |
| The Impact of Race and Ethnicity on Diffuse Large B-Cell Lymphoma (DLBCL) Outcomes within the Veterans Health Administration (VHA) MH Williams, RA Williams, JP Blaize, S Ananth, D Gregorio, GM Rosas, ... Blood 136, 3-4, 2020 | 2 | 2020 |
| The efficacy and safety of sorafenib in older adults with advanced hepatocellular carcinoma: An analysis of a majority Hispanic cohort SP Arora, S Ananth, N Ketchum, J Gelfond, J Michalek, D Mahalingam Journal of geriatric oncology 11 (7), 1157-1160, 2020 | 2 | 2020 |
| Post-CAR-T Minimal Residual Disease (MRD) Monitoring in Mantle Cell Lymphoma Enables Early Relapse Detection S Ananth, YJ Su, MP Hamilton, N Agarwal, WK Weng, S Dahiya, ... Blood 142, 1673, 2023 | 1 | 2023 |
| Real-world treatment patterns and outcomes in chronic lymphocytic leukemia (CLL) patients on novel agents in the US Veterans Health Administration (VHA) system: preliminary … Z Nooruddin, H Le, D McHugh, C Elesinmogun, S Galley, K Franklin, ... LEUKEMIA & LYMPHOMA 61, 61-63, 2020 | 1 | 2020 |
| Hodgkin Lymphoma Outcomes: Can We Expect Ethnic Parity in a Hispanic Prevalent Population? MJ Martinez, P Surapaneni, JF Garza, TW Snedden, S Ananth, ... Blood 134, 4056, 2019 | 1 | 2019 |
| The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA) A Ta, S Kaur, M Mader, K Franklin, M Williams, R Williams, JP Blaize, ... Leukemia & Lymphoma, 1-10, 2024 | | 2024 |
| The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration GR Souza, Z Nooruddin, S Lee, L Boyle, KT Lucero, S Ananth, K Franklin, ... Clinical Lymphoma Myeloma and Leukemia 24 (3), e67-e77, 2024 | | 2024 |
| Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B‐cell lymphoma in an adolescent patient D Lee, A Goyal, WL Wang, S Ananth, E Lau, MS Binkley, S Bharadwaj, ... Ejhaem 5 (1), 153-156, 2024 | | 2024 |
| Analysis of PET-CT Derived Radiomic Biomarkers with Efficacy, Safety, and Expansion of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed or Refractory Large B-Cell … S Bharadwaj, E Lau, A Hashmi, MP Hamilton, A Jensen, A Goyal, M Marar, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Differences in Characteristics and Outcomes of Central Nervous System Versus Systemic Relapse after First Line Therapy in DLBCL Patients: A Veterans Health Administration (VHA … AM Horowitz, Z Nooruddin, M Mader, K Franklin, M Williams, R Williams, ... Blood 142 (Supplement 1), 5161-5161, 2023 | | 2023 |
| Examining Racial Disparities in Diffuse Large B-Cell Lymphoma (DLBCL) Outcomes within the Veterans Health Administration (VHA) A Ta, S Kaur, M Mader, K Franklin, M Williams, R Williams, JP Blaize, ... Blood 142, 2398, 2023 | | 2023 |
| Survival Outcomes of Diffuse Large B Cell Lymphoma Beyond the Rituximab Era: Comprehensive Analysis of a Veteran Population within the Veterans Health Administration over 11 Years S Lee, S Kaur, M Mader, K Franklin, M Williams, R Williams, JP Blaize, ... Blood 142, 3785, 2023 | | 2023 |
| Real-World Applications of Guideline Based Diagnostic and Treatment Patterns for Diffuse Large B-Cell Lymphoma within the Veterans Health Administration (VHA) A Naqvi, S Kaur, M Mader, K Franklin, M Williams, R Williams, JP Blaize, ... Blood 142, 3795, 2023 | | 2023 |
| Analysis of PET-CT Derived Radiomic Biomarkers with Efficacy, Safety, and Expansion of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed or Refractory Large B-Cell … S Bharadwaj, E Lau, A Hashmi, MP Hamilton, A Jensen, A Goyal, M Marar, ... Blood 142, 2125, 2023 | | 2023 |
| Retrospective Analysis of Treatment Patterns and Outcomes in Geriatric Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in the Veterans Health Administration (VHA) H Latiolais, S Kaur, M Mader, K Franklin, M Williams, R Williams, ... Blood 142, 5156, 2023 | | 2023 |
| Appendix B: Cancer Epidemiology and Prevention JF Garza, M Janania, P Surapaneni, T Snedden, J Rollins, S Ananth, ... Advancing the Science of Cancer in Latinos, 225, 2023 | | 2023 |
